CORT # estimates

Related by string. * Corts . Corter . Cort : Cort Wagner . linebacker Cort Dennison . Cort Scheer . Mark Dalle Cort . Dalle Cort / # [012] . # [007] . # [016] . #s [002] . # [014] : #.# ov #-# . #-#:# pm [001] . ID # # . i Newswire #-#-# . Call #-#-# [002] / esti mates . ESTIMATES . ESTIMATE . esti mate : AS ESTIMATE ANTICIPATE BELIEVE . Results Beats Estimates . Reuters Estimates . Zacks Consensus Estimate * *

Related by context. Frequent words. (Click for all words.) 66 signal detection CTSD 65 Panzem R 64 2 methoxyestradiol 63 Completes Patient Enrollment 63 Initiates Phase II 63 peripherally acting 62 Panzem R NCD 62 TRANSDUR Sufentanil 62 TELINTRA 62 VIAject R 62 CORT # 62 ALN TTR 62 AzaSite Plus 62 ZFP Therapeutics 61 Romidepsin 61 Receives Orphan Drug Designation 61 VEGFR2 inhibitor 61 oncolytic virus therapies 61 Vytorin combines 61 ALN TTR# 60 concerning CombinatoRx 60 Meets Primary Endpoint 60 TRAIL receptor antibodies 60 Chemophase 60 Presents Positive 60 Drug Candidate 60 selectively induce apoptosis 59 inflammatory autoimmune diseases 59 GVAX R 59 NEBIDO R 59 Phase Ib clinical trials 59 Unit Dose Budesonide 59 Kinase Inhibitor 59 Commences Phase 59 R bortezomib 59 R sorafenib tablets 59 Trofex 58 Completes Enrollment 58 Pivotal Phase III 58 refractory chronic lymphocytic 58 topical non steroidal 58 siRNA therapeutic 58 MKC# 58 FDA Accepts 58 MEK inhibitors 58 forodesine HCl 58 novel anticancer 57 CEQ# 57 HGS ETR2 57 Entereg R 57 liposomal formulation 57 ® bortezomib 57 novel orally administered 57 Soliris TM eculizumab 57 topical anti infective 57 gets USFDA nod 57 IMC #B 57 TLR9 agonist 57 Kuvan R 56 PEG PAL 56 inflammation autoimmune diseases 56 active cellular immunotherapy 56 Pivotal Phase 56 Rosetta dependence 56 Initiates Phase 56 HepeX B 56 multi kinase inhibitor 56 Alnylam dependence 56 Tesetaxel 56 Locteron ® 56 immuno inflammatory diseases 56 CCX# 56 PEGylated 55 factor VIIa 55 Omigard TM 55 systemic lupus erythematosus lupus 55 Small Molecule 55 PEG SN# 55 epothilone 55 Pimavanserin 55 Thiarabine 55 OXi# 55 novel RNAi therapeutics 55 Phase III Clinical Trial 55 CMV vaccine 55 Recombinant Human 55 PSN# [002] 55 Nanobody 55 Darinaparsin 55 Initiate Phase 54 Metastatic Melanoma 54 Factor VIIa 54 Onalta 54 SIRT1 activators 54 KRN# 54 Inhalation Solution 54 histone deacetylase HDAC inhibitor 54 selectively inhibit 54 Cloretazine R VNP#M 54 JAK1 54 proteasome inhibitor

Back to home page